Introduction of cardiotocograph monitoring improves birth outcomes in women with preeclampsia in Ghana by Lawrence, Emma R. et al.
Acknowledgments
This study was supported by the Nancy Yeary Women’s Cancer
Research Foundation.
Conflict of interest
The authors have no conflicts of interest.
References
[1] Gupta N, Gupta A, Green M, Kang HS, Blankstein J. Placenta percreta at 17 weeks with
consecutive hysterectomy: a case report and review of the literature. Case Rep Obstet
Gynecol 2012;2012:734834.
[2] Pont M, Kouadio E, Fernandez MP, Bottaro M, Augros M, Bechet I, et al. Placenta
percreta at first trimester of pregnancy. Diagnostic and decision-making difficulties:
about a case and a review of the literature [in French]. J Gynecol Obstet Biol Reprod
(Paris) 2010;39(6):498–502.
[3] Thorp Jr JM, Wells SR, Wiest HH, Jeffries L, Lyles E. First-trimester diagnosis of placen-
ta previa percreta bymagnetic resonance imaging. Am J Obstet Gynecol 1998;178(3):
616–8.
[4] Naji O, Daemen A, Smith A, Abdallah Y, Bradburn E, Giggens R, et al. Does the presence
of a cesarean section scar influence the site of placental implantation and subsequent
migration in future pregnancies: a prospective case–control study. Ultrasound Obstet
Gynecol 2012;40(5):557–61.
http://dx.doi.org/10.1016/j.ijgo.2015.06.050
0020-7292/© 2015 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.
Introduction of cardiotocograph monitoring improves birth outcomes in
women with preeclampsia in Ghana
Emma R. Lawrence a,1, Eric L. Quarshie b, Kathleen F. Lewis c, Talya Peltzman d, Frank J. Anderson e,⁎
a University of Michigan Medical School, Ann Arbor, USA
b Department of Obstetrics and Gynecology, Komfo Anokye Teaching Hospital, Kumasi, Ghana
c University of Michigan College of Literature, Science and the Arts, Ann Arbor, USA
d Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, USA
e Department of Obstetrics and Gynecology, University of Michigan Health System, Ann Arbor, USA
a r t i c l e i n f o
Article history:
Received 30 March 2015
Received in revised form 9 June 2015







Perinatal mortality is closely linked to the availability of modern ob-
stetric care [1]. Electronic fetal monitoring, including cardiotocography
(CTG), is commonly utilized in high-income countries in the manage-
ment of high-risk pregnancies. However, CTG is often unavailable in
low-income settings,where rates of complicated pregnancy are highest.
The present retrospective observational study, conducted at Komfo
Anoyke Teaching Hospital (KATH), a tertiary referral center in Kumasi,
Ghana, between March 1 and August 2, 2012 examined the impact of
introducing CTG technology on perinatal death among women with
preeclampsia. Fetal outcomes were analyzed based on exposure to
CTG (monitoring status) and the period of delivery (pre- or post-CTG
implementation) to examine the impact of the procedure itself and
associated background impacts. Informed consent was not needed for
this study, as it was limited to retrospective analysis of de-identified
patient records. Approval for the present study was obtained from
the University of Michigan’s Institutional Review Board and the Ethics
Review Board at KATH.
Data were extracted from patient medical records for 12 weeks be-
fore (period A) and 8 weeks after (period B) the introduction of CTG
technology at KATH. The inclusion criteria consisted of clinical diagnosis
of preeclampsia, gestational age of at least 28weeks, and fetal heart rate
present on admission. Clinical diagnoses of preeclampsia were based on
written diagnoses from KATH physicians and were confirmed using the
2010 American College of Obstetricians and Gynecologists clinical
guidelines for the diagnosis of preeclampsia (those available at the
time of the study). These guidelines included persistently high blood
pressure (N140 mmHg systolic, N90 mmHg diastolic) and high levels
of proteinuria (N0.3 g) [2]. Records were categorized as monitored
if records indicated that the patient had received 20-minute CTG
monitoring on admission. All other patientswere categorized as unmon-
itored. Demographic and clinical datawere extracted to identify possible
confounders. A perinatal death was recordedwhen records indicated an
unexpected stillbirth or neonatal death prior to discharge. Data were
analyzed using SAS 9.4 (SAS Institute Inc., Cary, NC, USA). A two-sided
t-test was utilized to compare perinatal death rates. P b 0.05was consid-
ered significant.
In total, 372 records were analyzed. When comparing outcomes by
time period, a perinatal death was noted in 44 of 254 patient records
(17.3%) during period A, in comparison with eight of 118 patient re-
cords (6.8%) in period B. This represents a significant (P = 0.01) de-
crease in perinatal mortality following the implementation of CTG
technology. When period-B records were stratified by monitoring
status, a notable, but non-statistically significant (P = 0.1) reduction
in perinatal mortality was observed in the monitored group; two of
the 43 monitored patient records (4.7%) indicated a perinatal death in
comparison with six of the 75 unmonitored records (8.0%). There was
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no significant difference in the cesarean-delivery rates following CTG
implementation and no significant difference in patient demographic
characteristics across the time period and monitoring status.
The observed perinatal mortality rate across both study periods
was high. In part, this is likely a reflection of patient acuity at KATH,
which, as a tertiary referral hospital, often serves as the first point of
care for women with advanced pregnancy complications, potentially
with compromised fetuses on admission. Previous studies [3] have sug-
gested that adding fetal-assessment techniques decreases perinatal
mortality from fetal hypoxia. The significant improvement in perinatal
mortality in period B, regardless of monitoring status, suggests that
the process of implementing new technology may also be associated
with factors that benefit fetal outcomes (e.g., increased training, clinical
awareness). The currently available technology only allows for a sub-
group of high-risk women to receive CTG assessments. The demon-
strated improvement in perinatal mortality observed illustrates an
opportunity to fill a gap in maternal care that could offer high-impact
improvements for perinatal outcomes. Full implementation of appropri-
ately applied fetal-assessment technology offers significant potential
in allowing obstetricians to end preventable early-neonatal mortality
and stillbirth [4].
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